Why Iovance Biotherapeutics shares rose today
29.12.2023
Shares of Iovance Biotherapeutics (NASDAQ: IOVA) rose 18.7 percent on Thursday as investors assessed the impact of yesterday's U.S. Food and Drug Administration ban on its cancer treatment clinical trial. Today's gains nearly offset the...
Read more